← back to search

Richard P. Koche

New York Proton Center · US
Area of research
Molecular Biology · Hematology
Research interest
Research interests include Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation, Myeloproliferative Neoplasms: Diagnosis and Treatment, and Protein Degradation and Inhibitors.
h-index
62
citations
17,534
works
620
NIH funding
primary concept
Biology
email

Recent publications

Mechanical confinement governs phenotypic plasticity in melanoma
Nature 2025cited by 26position: middledoi
A nucleosome switch primes hepatitis B virus infection
Cell 2025cited by 25position: middledoi
Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance
Nature Communications 2025cited by 15position: middledoi
A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model
Cancer Discovery 2025cited by 7position: middledoi
Extrachromosomal DNA micronucleation constrains tumour fitness and improves patient survival
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 5position: middledoi
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence
Nature Cancer 2025cited by 5position: middledoi
Extracellular matrix regulates lineage plasticity in prostate cancer through YAP/TEAD
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 1position: middledoi
An epigenetic barrier sets the timing of human neuronal maturation
Nature 2024cited by 200position: middledoi
Ageing limits stemness and tumorigenesis by reprogramming iron homeostasis
Nature 2024cited by 57position: middledoi
SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing
Journal of Hematology & Oncology 2024cited by 32position: middledoi
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation
Signal Transduction and Targeted Therapy 2024cited by 23position: middledoi
Intercellular extrachromosomal DNA copy-number heterogeneity drives neuroblastoma cell state diversity
Cell Reports 2024cited by 23position: middledoi
Passenger Gene Coamplifications Create Collateral Therapeutic Vulnerabilities in Cancer
Cancer Discovery 2024cited by 15position: middledoi
Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer
Cell Reports 2024cited by 12position: middledoi
Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis
Science 2023cited by 202position: middledoi
Epigenetic dysregulation from chromosomal transit in micronuclei
Nature 2023cited by 114position: middledoi
Parallel sequencing of extrachromosomal circular DNAs and transcriptomes in single cancer cells
Nature Genetics 2023cited by 81position: middledoi
A reversible epigenetic memory of inflammatory injury controls lineage plasticity and tumor initiation in the mouse pancreas
Developmental Cell 2023cited by 52position: middledoi
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers
Science Translational Medicine 2023cited by 44position: middledoi
Chromatin regulation of transcriptional enhancers and cell fate by the Sotos syndrome gene NSD1
Molecular Cell 2023cited by 42position: middledoi
GABA Regulates Electrical Activity and Tumor Initiation in Melanoma
Cancer Discovery 2023cited by 40position: middledoi
KMT2D suppresses Sonic hedgehog-driven medulloblastoma progression and metastasis
iScience 2023cited by 21position: middledoi
MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer
eLife 2023cited by 20position: middledoi
Mutational topography reflects clinical neuroblastoma heterogeneity
Cell Genomics 2023cited by 14position: middledoi
Intercellular extrachromosomal DNA copy number heterogeneity drives cancer cell state diversity
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 5position: middledoi
Anatomic position determines oncogenic specificity in melanoma
Nature 2022cited by 96position: middledoi
CRISPR screening uncovers a central requirement for HHEX in pancreatic lineage commitment and plasticity restriction
Nature Cell Biology 2022cited by 39position: middledoi
BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation
Blood 2022cited by 33position: middledoi
Epigenetic plasticity cooperates with emergent cell-cell interactions to drive neoplastic tissue remodeling in the pancreas
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 6position: middledoi
Amplicon structure creates collateral therapeutic vulnerability in cancer
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Scott W. Lowe · Memorial Sloan Kettering Cancer Center13 papers (2018–2025)Scott A. Armstrong · Harvard University8 papers (2015–2023)Ross L. Levine · Leukemia and Lymphoma Society7 papers (2012–2022)Dana Pe’er · Howard Hughes Medical Institute6 papers (2019–2025)Elisa de Stanchina · European Molecular Biology Laboratory6 papers (2016–2025)Yu-Jui Ho · Research Center for Environmental Changes, Academia Sinica6 papers (2019–2025)Chun‐Wei Chen · Toyota Motor Corporation (Switzerland)6 papers (2015–2023)Geulah Livshits · Memorial Sloan Kettering Cancer Center5 papers (2018–2025)Timour Baslan · University of Pennsylvania5 papers (2019–2025)Anton G. Henssen · Johns Hopkins University5 papers (2015–2024)Direna Alonso‐Curbelo · Institute for Research in Biomedicine5 papers (2018–2025)Johannes H. Schulte · Universitätsklinikum Tübingen5 papers (2015–2024)Angelika Eggert · DKFZ-ZMBH Alliance5 papers (2015–2024)Doron Betel · Cornell University4 papers (2019–2024)Raajit K. Rampal · Icahn School of Medicine at Mount Sinai4 papers (2017–2022)Kerstin Haase · German Cancer Society4 papers (2022–2024)Ronan Chaligné · Memorial Sloan Kettering Cancer Center4 papers (2022–2025)Yingqian A. Zhan · University of Idaho4 papers (2021–2024)Christina S. Leslie · Center for Cancer Research4 papers (2019–2024)John P. Morris · UNC Lineberger Comprehensive Cancer Center4 papers (2018–2023)